KEGG   PATHWAY: ko05017
Entry
ko05017                     Pathway                                
Name
Spinocerebellar ataxia
Description
The autosomal dominant spinocerebellar ataxias (SCAs) are a group of progressive neurodegenerative diseases characterised by loss of balance and motor coordination due to the primary dysfunction of the cerebellum. Compelling evidence points to major aetiological roles for transcriptional dysregulation, protein aggregation and clearance, autophagy, the ubiquitin-proteasome system, alterations of calcium homeostasis, mitochondria defects, toxic RNA gain-of-function mechanisms and eventual cell death with apoptotic features of neurons during SCA disease progression.
Class
Human Diseases; Neurodegenerative disease
Pathway map
ko05017  Spinocerebellar ataxia
ko05017

Disease
H00063  Spinocerebellar ataxia (SCA)
Orthology
K04966  transient receptor potential cation channel subfamily C member 3
K04603  metabotropic glutamate receptor 1
K04634  guanine nucleotide-binding protein G(q) subunit alpha
K05858  phosphatidylinositol phospholipase C, beta [EC:3.1.4.11]
K02677  classical protein kinase C alpha type [EC:2.7.11.13]
K19662  classical protein kinase C beta type [EC:2.7.11.13]
K19663  classical protein kinase C gamma type [EC:2.7.11.13]
K05197  glutamate receptor 1
K05198  glutamate receptor 2
K05199  glutamate receptor 3
K04344  voltage-dependent calcium channel P/Q type alpha-1A
K04958  inositol 1,4,5-triphosphate receptor type 1
K04959  inositol 1,4,5-triphosphate receptor type 2
K04960  inositol 1,4,5-triphosphate receptor type 3
K23625  ataxin 2/2L
K11863  Ataxin-3 [EC:3.4.22.-]
K04961  ryanodine receptor 1
K15840  proenkephalin B (prodynorphin)
K05208  glutamate receptor ionotropic, NMDA 1
K05209  glutamate receptor ionotropic, NMDA 2A
K05210  glutamate receptor ionotropic, NMDA 2B
K05211  glutamate receptor ionotropic, NMDA 2C
K05212  glutamate receptor ionotropic, NMDA 2D
K05213  glutamate receptor ionotropic, NMDA 3A
K05214  glutamate receptor ionotropic, NMDA 3B
K20858  calcium uniporter protein, mitochondrial
K05862  voltage-dependent anion channel protein 1
K15040  voltage-dependent anion channel protein 2
K15041  voltage-dependent anion channel protein 3
K05863  solute carrier family 25 (mitochondrial adenine nucleotide translocator), member 4/5/6/31
K09565  peptidyl-prolyl isomerase F (cyclophilin D) [EC:5.2.1.8]
K08738  cytochrome c
K08956  AFG3 family protein [EC:3.4.24.-]
K23010  metalloendopeptidase OMA1, mitochondrial [EC:3.4.24.-]
K17079  optic atrophy protein 1 [EC:3.6.5.5]
K23920  fibroblast growth factor 14
K23932  spectrin beta, non-erythrocytic 2
K02730  20S proteasome subunit alpha 1 [EC:3.4.25.1]
K02726  20S proteasome subunit alpha 2 [EC:3.4.25.1]
K02728  20S proteasome subunit alpha 3 [EC:3.4.25.1]
K02731  20S proteasome subunit alpha 4 [EC:3.4.25.1]
K02729  20S proteasome subunit alpha 5 [EC:3.4.25.1]
K02725  20S proteasome subunit alpha 6 [EC:3.4.25.1]
K02727  20S proteasome subunit alpha 7 [EC:3.4.25.1]
K02738  20S proteasome subunit beta 1 [EC:3.4.25.1]
K02739  20S proteasome subunit beta 2 [EC:3.4.25.1]
K02735  20S proteasome subunit beta 3 [EC:3.4.25.1]
K02734  20S proteasome subunit beta 4 [EC:3.4.25.1]
K02737  20S proteasome subunit beta 5 [EC:3.4.25.1]
K02732  20S proteasome subunit beta 6 [EC:3.4.25.1]
K02736  20S proteasome subunit beta 7 [EC:3.4.25.1]
K03061  26S proteasome regulatory subunit T1
K03062  26S proteasome regulatory subunit T2
K03063  26S proteasome regulatory subunit T3
K03064  26S proteasome regulatory subunit T4
K03065  26S proteasome regulatory subunit T5
K03066  26S proteasome regulatory subunit T6
K03028  26S proteasome regulatory subunit N1
K03032  26S proteasome regulatory subunit N2
K03033  26S proteasome regulatory subunit N3
K06693  26S proteasome regulatory subunit N4
K03035  26S proteasome regulatory subunit N5
K03036  26S proteasome regulatory subunit N6
K03037  26S proteasome regulatory subunit N7
K03038  26S proteasome regulatory subunit N8
K03039  26S proteasome regulatory subunit N9
K03029  26S proteasome regulatory subunit N10
K03030  26S proteasome regulatory subunit N11
K03031  26S proteasome regulatory subunit N12
K06691  26S proteasome regulatory subunit N13
K10881  26 proteasome complex subunit DSS1
K08852  serine/threonine-protein kinase/endoribonuclease IRE1 [EC:2.7.11.1 3.1.26.-]
K03173  TNF receptor-associated factor 2 [EC:2.3.2.27]
K04426  mitogen-activated protein kinase kinase kinase 5 [EC:2.7.11.25]
K04440  mitogen-activated protein kinase 8/9/10 (c-Jun N-terminal kinase) [EC:2.7.11.24]
K23616  ataxin 1/1L
K11304  histone acetyltransferase HTATIP [EC:2.3.1.48]
K08532  RAR-related orphan receptor alpha
K05853  P-type Ca2+ transporter type 2A [EC:7.2.2.10]
K05617  solute carrier family 1 (high affinity glutamate/aspartate transporter), member 6
K20225  capicua transcriptional repressor
K17943  pumilio RNA-binding family
K03120  transcription initiation factor TFIID TATA-box-binding protein
K06053  recombining binding protein suppressor of hairless
K04684  transcription factor Sp1
K03124  transcription initiation factor TFIIB
K08064  nuclear transcription factor Y, alpha
K09027  X box-binding protein 1
K09064  myogenic factor 3
K07203  serine/threonine-protein kinase mTOR [EC:2.7.11.1]
K21357  serine/threonine-protein kinase ULK1 [EC:2.7.11.1]
K08269  serine/threonine-protein kinase ULK2 [EC:2.7.11.1]
K19730  autophagy-related protein 101
K08331  autophagy-related protein 13
K17589  RB1-inducible coiled-coil protein 1
K17985  activating molecule in BECN1-regulated autophagy protein 1
K08334  beclin
K08333  phosphoinositide-3-kinase, regulatory subunit 4 [EC:2.7.11.1]
K17889  beclin 1-associated autophagy-related key regulator
K21246  nuclear receptor-binding factor 2
K00914  phosphatidylinositol 3-kinase [EC:2.7.1.137]
K17906  autophagy-related protein 2
K17908  autophagy-related protein 18
K04889  potassium voltage-gated channel Shaw-related subfamily C member 3
K04893  potassium voltage-gated channel Shal-related subfamily D member 3
K06249  reelin [EC:3.4.21.-]
K20053  very low-density lipoprotein receptor
K20054  disabled homolog 1
K00922  phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha/beta/delta [EC:2.7.1.153]
K02649  phosphoinositide-3-kinase regulatory subunit alpha/beta/delta
K04456  RAC serine/threonine-protein kinase [EC:2.7.11.1]
K17680  twinkle protein [EC:5.6.2.3]
K23933  ATXN8 opposite strand lncRNA
K19323  ataxin-10
K19324  protein BEAN1
K14564  nucleolar protein 56
Compound
C00025  L-Glutamate
C00076  Calcium cation
C00165  Diacylglycerol
C00238  Potassium cation
C01245  D-myo-Inositol 1,4,5-trisphosphate
C01330  Sodium cation
C04549  1-Phosphatidyl-1D-myo-inositol 3-phosphate
Reference
  Authors
Matilla-Duenas A, Sanchez I, Corral-Juan M, Davalos A, Alvarez R, Latorre P
  Title
Cellular and molecular pathways triggering neurodegeneration in the spinocerebellar ataxias.
  Journal
Cerebellum 9:148-66 (2010)
DOI:10.1007/s12311-009-0144-2
Reference
  Authors
Duenas AM, Goold R, Giunti P
  Title
Molecular pathogenesis of spinocerebellar ataxias.
  Journal
Brain 129:1357-70 (2006)
DOI:10.1093/brain/awl081
Reference
  Authors
Mark MD, Schwitalla JC, Groemmke M, Herlitze S
  Title
Keeping Our Calcium in Balance to Maintain Our Balance.
  Journal
Biochem Biophys Res Commun 483:1040-1050 (2017)
DOI:10.1016/j.bbrc.2016.07.020
Reference
  Authors
Egorova PA, Bezprozvanny IB
  Title
Inositol 1,4,5-trisphosphate receptors and neurodegenerative disorders.
  Journal
FEBS J 285:3547-3565 (2018)
DOI:10.1111/febs.14366
Reference
  Authors
Shimobayashi E, Kapfhammer JP
  Title
Calcium Signaling, PKC Gamma, IP3R1 and CAR8 Link Spinocerebellar Ataxias and Purkinje Cell Dendritic Development.
  Journal
Curr Neuropharmacol 16:151-159 (2018)
DOI:10.2174/1570159X15666170529104000
Reference
  Authors
Kasumu A, Bezprozvanny I
  Title
Deranged calcium signaling in Purkinje cells and pathogenesis in spinocerebellar ataxia 2 (SCA2) and other ataxias.
  Journal
Cerebellum 11:630-9 (2012)
DOI:10.1007/s12311-010-0182-9
Reference
  Authors
Egorova P, Popugaeva E, Bezprozvanny I
  Title
Disturbed calcium signaling in spinocerebellar ataxias and Alzheimer's disease.
  Journal
Semin Cell Dev Biol 40:127-33 (2015)
DOI:10.1016/j.semcdb.2015.03.010
Reference
  Authors
Hisatsune C, Hamada K, Mikoshiba K
  Title
Ca(2+) signaling and spinocerebellar ataxia.
  Journal
Biochim Biophys Acta Mol Cell Res 1865:1733-1744 (2018)
DOI:10.1016/j.bbamcr.2018.05.009
Reference
  Authors
Takada SH, Ikebara JM, de Sousa E, Cardoso DS, Resende RR, Ulrich H, Ruckl M, Rudiger S, Kihara AH
  Title
Determining the Roles of Inositol Trisphosphate Receptors in Neurodegeneration: Interdisciplinary Perspectives on a Complex Topic.
  Journal
Mol Neurobiol 54:6870-6884 (2017)
DOI:10.1007/s12035-016-0205-8
Reference
  Authors
Brown SA, Loew LM
  Title
Integration of modeling with experimental and clinical findings synthesizes and refines the central role of inositol 1,4,5-trisphosphate receptor 1 in spinocerebellar ataxia.
  Journal
Front Neurosci 8:453 (2014)
DOI:10.3389/fnins.2014.00453
Reference
  Authors
Inoue T
  Title
Dynamics of calcium and its roles in the dendrite of the cerebellar Purkinje cell.
  Journal
Keio J Med 52:244-9 (2003)
DOI:10.2302/kjm.52.244
Reference
  Authors
Adachi N, Kobayashi T, Takahashi H, Kawasaki T, Shirai Y, Ueyama T, Matsuda T, Seki T, Sakai N, Saito N
  Title
Enzymological analysis of mutant protein kinase Cgamma causing spinocerebellar ataxia type 14 and dysfunction in Ca2+ homeostasis.
  Journal
J Biol Chem 283:19854-63 (2008)
DOI:10.1074/jbc.M801492200
Reference
  Authors
Smeets CJ, Jezierska J, Watanabe H, Duarri A, Fokkens MR, Meijer M, Zhou Q, Yakovleva T, Boddeke E, den Dunnen W, van Deursen J, Bakalkin G, Kampinga HH, van de Sluis B, Verbeek DS
  Title
Elevated mutant dynorphin A causes Purkinje cell loss and motor dysfunction in spinocerebellar ataxia type 23.
  Journal
Brain 138:2537-52 (2015)
DOI:10.1093/brain/awv195
Reference
  Authors
Tulli S, Del Bondio A, Baderna V, Mazza D, Codazzi F, Pierson TM, Ambrosi A, Nolte D, Goizet C, Toro C, Baets J, Deconinck T, DeJonghe P, Mandich P, Casari G, Maltecca F
  Title
Pathogenic variants in the AFG3L2 proteolytic domain cause SCA28 through haploinsufficiency and proteostatic stress-driven OMA1 activation.
  Journal
J Med Genet 56:499-511 (2019)
DOI:10.1136/jmedgenet-2018-105766
Reference
  Authors
Mancini C, Hoxha E, Iommarini L, Brussino A, Richter U, Montarolo F, Cagnoli C, Parolisi R, Gondor Morosini DI, Nicolo V, Maltecca F, Muratori L, Ronchi G, Geuna S, Arnaboldi F, Donetti E, Giorgio E, Cavalieri S, Di Gregorio E, Pozzi E, Ferrero M, Riberi E, Casari G, Altruda F, Turco E, Gasparre G, Battersby BJ, Porcelli AM, Ferrero E, Brusco A, Tempia F
  Title
Mice harbouring a SCA28 patient mutation in AFG3L2 develop late-onset ataxia associated with enhanced mitochondrial proteotoxicity.
  Journal
Neurobiol Dis 124:14-28 (2019)
DOI:10.1016/j.nbd.2018.10.018
Reference
  Authors
Becker EBE
  Title
From Mice to Men: TRPC3 in Cerebellar Ataxia.
  Journal
Cerebellum 16:877-879 (2017)
DOI:10.1007/s12311-015-0663-y
Reference
  Authors
Hoxha E, Tempia F, Lippiello P, Miniaci MC
  Title
Modulation, Plasticity and Pathophysiology of the Parallel Fiber-Purkinje Cell Synapse.
  Journal
Front Synaptic Neurosci 8:35 (2016)
DOI:10.3389/fnsyn.2016.00035
Reference
  Authors
Yan H, Pablo JL, Pitt GS
  Title
FGF14 regulates presynaptic Ca2+ channels and synaptic transmission.
  Journal
Cell Rep 4:66-75 (2013)
DOI:10.1016/j.celrep.2013.06.012
Reference
  Authors
Tada M, Nishizawa M, Onodera O
  Title
Roles of inositol 1,4,5-trisphosphate receptors in spinocerebellar ataxias.
  Journal
Neurochem Int 94:1-8 (2016)
DOI:10.1016/j.neuint.2016.01.007
Reference
  Authors
Pietrobon D
  Title
CaV2.1 channelopathies.
  Journal
Pflugers Arch 460:375-93 (2010)
DOI:10.1007/s00424-010-0802-8
Reference
  Authors
Matsuyama Z, Yanagisawa NK, Aoki Y, Black JL 3rd, Lennon VA, Mori Y, Imoto K, Inuzuka T
  Title
Polyglutamine repeats of spinocerebellar ataxia 6 impair the cell-death-preventing effect of CaV2.1 Ca2+ channel--loss-of-function cellular model of SCA6.
  Journal
Neurobiol Dis 17:198-204 (2004)
DOI:10.1016/j.nbd.2004.07.013
Reference
  Authors
Nishitoh H, Matsuzawa A, Tobiume K, Saegusa K, Takeda K, Inoue K, Hori S, Kakizuka A, Ichijo H
  Title
ASK1 is essential for endoplasmic reticulum stress-induced neuronal cell death triggered by expanded polyglutamine repeats.
  Journal
Genes Dev 16:1345-55 (2002)
DOI:10.1101/gad.992302
Reference
  Authors
Evers MM, Toonen LJ, van Roon-Mom WM
  Title
Ataxin-3 protein and RNA toxicity in spinocerebellar ataxia type 3: current insights and emerging therapeutic strategies.
  Journal
Mol Neurobiol 49:1513-31 (2014)
DOI:10.1007/s12035-013-8596-2
Reference
  Authors
Ashkenazi A, Bento CF, Ricketts T, Vicinanza M, Siddiqi F, Pavel M, Squitieri F, Hardenberg MC, Imarisio S, Menzies FM, Rubinsztein DC
  Title
Polyglutamine tracts regulate autophagy.
  Journal
Autophagy 13:1613-1614 (2017)
DOI:10.1080/15548627.2017.1336278
Reference
  Authors
Chen RH, Chen YH, Huang TY
  Title
Ubiquitin-mediated regulation of autophagy.
  Journal
J Biomed Sci 26:80 (2019)
DOI:10.1186/s12929-019-0569-y
Reference
  Authors
Serra HG, Duvick L, Zu T, Carlson K, Stevens S, Jorgensen N, Lysholm A, Burright E, Zoghbi HY, Clark HB, Andresen JM, Orr HT
  Title
RORalpha-mediated Purkinje cell development determines disease severity in adult SCA1 mice.
  Journal
Cell 127:697-708 (2006)
DOI:10.1016/j.cell.2006.09.036
Reference
  Authors
Rousseaux MWC, Tschumperlin T, Lu HC, Lackey EP, Bondar VV, Wan YW, Tan Q, Adamski CJ, Friedrich J, Twaroski K, Chen W, Tolar J, Henzler C, Sharma A, Bajic A, Lin T, Duvick L, Liu Z, Sillitoe RV, Zoghbi HY, Orr HT
  Title
ATXN1-CIC Complex Is the Primary Driver of Cerebellar Pathology in Spinocerebellar Ataxia Type 1 through a Gain-of-Function Mechanism.
  Journal
Neuron 97:1235-1243.e5 (2018)
DOI:10.1016/j.neuron.2018.02.013
Reference
  Authors
Jimenez G, Shvartsman SY, Paroush Z
  Title
The Capicua repressor--a general sensor of RTK signaling in development and disease.
  Journal
J Cell Sci 125:1383-91 (2012)
DOI:10.1242/jcs.092965
Reference
  Authors
Gennarino VA, Palmer EE, McDonell LM, Wang L, Adamski CJ, Koire A, See L, Chen CA, Schaaf CP, Rosenfeld JA, Panzer JA, Moog U, Hao S, Bye A, Kirk EP, Stankiewicz P, Breman AM, McBride A, Kandula T, Dubbs HA, Macintosh R, Cardamone M, Zhu Y, Ying K, Dias KR, Cho MT, Henderson LB, Baskin B, Morris P, Tao J, Cowley MJ, Dinger ME, Roscioli T, Caluseriu O, Suchowersky O, Sachdev RK, Lichtarge O, Tang J, Boycott KM, Holder JL Jr, Zoghbi HY
  Title
A Mild PUM1 Mutation Is Associated with Adult-Onset Ataxia, whereas Haploinsufficiency Causes Developmental Delay and Seizures.
  Journal
Cell 172:924-936.e11 (2018)
DOI:10.1016/j.cell.2018.02.006
Reference
  Authors
Irie T, Matsuzaki Y, Sekino Y, Hirai H
  Title
Kv3.3 channels harbouring a mutation of spinocerebellar ataxia type 13 alter excitability and induce cell death in cultured cerebellar Purkinje cells.
  Journal
J Physiol 592:229-47 (2014)
DOI:10.1113/jphysiol.2013.264309
Reference
  Authors
Bushart DD, Murphy GG, Shakkottai VG
  Title
Precision medicine in spinocerebellar ataxias: treatment based on common mechanisms of disease.
  Journal
Ann Transl Med 4:25 (2016)
DOI:10.3978/j.issn.2305-5839.2016.01.06
Reference
  Authors
Hsiao CT, Fu SJ, Liu YT, Lu YH, Zhong CY, Tang CY, Soong BW, Jeng CJ
  Title
Novel SCA19/22-associated KCND3 mutations disrupt human KV 4.3 protein biosynthesis and channel gating.
  Journal
Hum Mutat 40:2088-2107 (2019)
DOI:10.1002/humu.23865
Reference
  Authors
Duarri A, Lin MC, Fokkens MR, Meijer M, Smeets CJ, Nibbeling EA, Boddeke E, Sinke RJ, Kampinga HH, Papazian DM, Verbeek DS
  Title
Spinocerebellar ataxia type 19/22 mutations alter heterocomplex Kv4.3 channel function and gating in a dominant manner.
  Journal
Cell Mol Life Sci 72:3387-99 (2015)
DOI:10.1007/s00018-015-1894-2
Reference
  Authors
Matilla-Duenas A, Volpini V
  Title
Spinocerebellar Ataxia Type 37
  Journal
GeneReviews (1993)
Reference
  Authors
Corral-Juan M, Serrano-Munuera C, Rabano A, Cota-Gonzalez D, Segarra-Roca A, Ispierto L, Cano-Orgaz AT, Adarmes AD, Mendez-Del-Barrio C, Jesus S, Mir P, Volpini V, Alvarez-Ramo R, Sanchez I, Matilla-Duenas A
  Title
Clinical, genetic and neuropathological characterization of spinocerebellar ataxia type 37.
  Journal
Brain 141:1981-1997 (2018)
DOI:10.1093/brain/awy137
Reference
  Authors
Swinnen B, Robberecht W, Van Den Bosch L
  Title
RNA toxicity in non-coding repeat expansion disorders.
  Journal
EMBO J e101112 (2019)
DOI:10.15252/embj.2018101112
Reference
  Authors
Ishikawa K, Nagai Y
  Title
Molecular Mechanisms and Future Therapeutics for Spinocerebellar Ataxia Type 31 (SCA31).
  Journal
Neurotherapeutics 10.1007/s13311-019-00804-6 (2019)
DOI:10.1007/s13311-019-00804-6
Reference
  Authors
Niimi Y, Takahashi M, Sugawara E, Umeda S, Obayashi M, Sato N, Ishiguro T, Higashi M, Eishi Y, Mizusawa H, Ishikawa K
  Title
Abnormal RNA structures (RNA foci) containing a penta-nucleotide repeat (UGGAA)n in the Purkinje cell nucleus is associated with spinocerebellar ataxia type 31 pathogenesis.
  Journal
Neuropathology 33:600-11 (2013)
DOI:10.1111/neup.12032
Reference
  Authors
Kobayashi H, Abe K, Matsuura T, Ikeda Y, Hitomi T, Akechi Y, Habu T, Liu W, Okuda H, Koizumi A
  Title
Expansion of intronic GGCCTG hexanucleotide repeat in NOP56 causes SCA36, a type of spinocerebellar ataxia accompanied by motor neuron involvement.
  Journal
Am J Hum Genet 89:121-30 (2011)
DOI:10.1016/j.ajhg.2011.05.015
Related
pathway
ko03050  Proteasome
ko04020  Calcium signaling pathway
ko04140  Autophagy - animal
ko04141  Protein processing in endoplasmic reticulum
ko04210  Apoptosis
ko04724  Glutamatergic synapse
ko04730  Long-term depression
LinkDB

DBGET integrated database retrieval system